We are updating our Terms of Use and Privacy Statement.
You are using an older browser version. Please use a supported version for the best MSN experience.

ProShares Ultra Nasdaq Biotechnology

NASDAQ: BIB
47.32
+0.64
+1.37%
8/26/2016 4:00 PM EDT
5 Years
  • Open

    46.68

  • Previous Close

    46.68

  • Vol (3-Month Avg.)

    696.41k

  • Day's Range

    46.46-48.20

  • 52 week range

    33.97-86.77

  • Net Assets

    478.31M

  • Yield

    0.00%

  • Category

    Trading--Leveraged Equity

  • Morningstar Risk

    -

Profile

Name of Issuer

ProShares

Expenses

0.95%

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.

Inception

4/6/2010

AdChoices
AdChoices
image beaconimage beaconimage beacon